Preben Jakobsen

970 total citations
36 papers, 815 citations indexed

About

Preben Jakobsen is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Preben Jakobsen has authored 36 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Pharmacology. Recurrent topics in Preben Jakobsen's work include Acute Lymphoblastic Leukemia research (6 papers), Retinoids in leukemia and cellular processes (5 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Preben Jakobsen is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Retinoids in leukemia and cellular processes (5 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Preben Jakobsen collaborates with scholars based in Denmark, Germany and United States. Preben Jakobsen's co-authors include F. Andreasen, Anders Jakobsen, Henrik Daa Schrøder, Birgitte Klug Albertsen, Kjeld Schmiegelow, Frederik Grønhøj Larsen, Hans‐Joachim Müller, Knud Kragballe, F. Nielsen‐Kudsk and Vassilios I. Avramis and has published in prestigious journals such as Journal of Hepatology, Archives of Biochemistry and Biophysics and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Preben Jakobsen

34 papers receiving 782 citations

Peers

Preben Jakobsen
N. A. Samaan United States
Stewart L. MacLeod United States
Anke Geick Germany
Claudia Marx Germany
Daniel J. Crona United States
Jin Q Kim South Korea
Maria Azrad United States
N. A. Samaan United States
Preben Jakobsen
Citations per year, relative to Preben Jakobsen Preben Jakobsen (= 1×) peers N. A. Samaan

Countries citing papers authored by Preben Jakobsen

Since Specialization
Citations

This map shows the geographic impact of Preben Jakobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preben Jakobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preben Jakobsen more than expected).

Fields of papers citing papers by Preben Jakobsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preben Jakobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preben Jakobsen. The network helps show where Preben Jakobsen may publish in the future.

Co-authorship network of co-authors of Preben Jakobsen

This figure shows the co-authorship network connecting the top 25 collaborators of Preben Jakobsen. A scholar is included among the top collaborators of Preben Jakobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Preben Jakobsen. Preben Jakobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andersen, Ljubica Vukelic, et al.. (2008). Samfundserhvervet pneumoni--behandling. Ugeskrift for Læger. 170(3).
2.
Vestergaard, Esben Thyssen, Troels Krarup Hansen, Lars Christian Gormsen, et al.. (2007). Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects. American Journal of Physiology-Endocrinology and Metabolism. 292(6). E1829–E1836. 87 indexed citations
3.
Albertsen, Birgitte Klug, Henrik Hasle, Niels Clausen, Henrik Daa Schrøder, & Preben Jakobsen. (2004). Pain intensity and bioavailability of intramuscular asparaginase and a local anesthetic: A double‐blinded study. Pediatric Blood & Cancer. 44(3). 255–258. 7 indexed citations
4.
Mortensen, Ulrik Markus, Jens Erik Nielsen‐Kudsk, Preben Jakobsen, & Torsten Toftegaard Nielsen. (2003). Glibenclamide blunts coronary flow reserve induced by adenosine and dipyridamole. Scandinavian Cardiovascular Journal. 37(5). 247–252. 1 indexed citations
5.
Albertsen, Birgitte Klug, Henrik Daa Schrøder, Preben Jakobsen, et al.. (2002). Antibody formation during intravenous and intramuscular therapy with Erwinia asparaginase*. Medical and Pediatric Oncology. 38(5). 310–316. 49 indexed citations
6.
Albertsen, Birgitte Klug, Kjeld Schmiegelow, Henrik Daa Schrøder, et al.. (2002). Anti- Erwinia asparaginase antibodies during treatment of childhood acute lymphoblastic leukemia and their relationship to outcome: a case-control study. Cancer Chemotherapy and Pharmacology. 50(2). 117–120. 15 indexed citations
7.
Albertsen, Birgitte Klug, Henrik Daa Schrøder, Jørgen Ingerslev, et al.. (2001). Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system. British Journal of Haematology. 115(4). 983–990. 51 indexed citations
8.
Albertsen, Birgitte Klug, Preben Jakobsen, Henrik Daa Schrøder, Kjeld Schmiegelow, & Niels Carlsen. (2001). Pharmacokinetics of Erwinia asparaginase after intravenous and intramuscular administration. Cancer Chemotherapy and Pharmacology. 48(1). 77–82. 32 indexed citations
9.
Albertsen, Birgitte Klug, et al.. (2001). Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries. British Journal of Clinical Pharmacology. 52(4). 433–437. 39 indexed citations
11.
Ottesen, Lone H., Allan Flyvbjerg, Preben Jakobsen, & Flemming Bendtsen. (1997). The pharmacokinetics of octreotide in cirrhosis and in healthy man. Journal of Hepatology. 26(5). 1018–1025. 26 indexed citations
12.
Jakobsen, Preben, et al.. (1992). Renal handling of carboplatin. Cancer Chemotherapy and Pharmacology. 30(4). 317–320. 19 indexed citations
13.
Larsen, Frederik Grønhøj, et al.. (1991). The Pharmacokinetics of Acitretin and its 13‐cis‐metabolite in Psoriatic Patients. The Journal of Clinical Pharmacology. 31(5). 477–483. 14 indexed citations
14.
Jakobsen, Preben, Eva Steiness, Lars Bastholt, et al.. (1991). Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 28(1). 63–68. 34 indexed citations
15.
Jakobsen, Preben, Lars Bastholt, M. Dalmark, et al.. (1991). A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement. Cancer Chemotherapy and Pharmacology. 28(6). 465–469. 49 indexed citations
16.
Larsen, Frederik Grønhøj, F. Nielsen‐Kudsk, Preben Jakobsen, Henrik Daa Schrøder, & Knud Kragballe. (1990). Interaction of Etretinate with Methotrexate Pharmacokinetics in Psoriatic Patients. The Journal of Clinical Pharmacology. 30(9). 802–807. 14 indexed citations
17.
Birkebæk, Niels, et al.. (1988). The effect of nifedipine and captopril on platelet activation and prostanoid production in essential hypertension. Journal of Hypertension. 6(4). S378–380. 13 indexed citations
18.
Nielsen‐Kudsk, F., et al.. (1988). Bepridil, Myocardial Accumulation Kinetics and Dynamic Effects in the Isolated Rabbit Heart. Pharmacology & Toxicology. 63(2). 122–128. 2 indexed citations
19.
Larsen, Frederik Grønhøj, et al.. (1988). Pharmacokinetics of Etretin and Etretinate during Long‐Term Treatment of Psoriasis Patients. Pharmacology & Toxicology. 62(3). 159–165. 33 indexed citations
20.
Larsen, Frederik Grønhøj, et al.. (1987). Single Dose Pharmacokinetics of Etretin and Etretinate in Psoriatic Patients. Pharmacology & Toxicology. 61(2). 85–88. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026